Latest news
The Pharma Letter M&A round-up – July 2026 - The Pharma LetterThe Pharma Letter · Mon, 03 Aug 2026 13:49:16 GMTThe week in pharma: action, reaction and insight – week to July 31, 2026 - The Pharma LetterThe Pharma Letter · Sun, 02 Aug 2026 12:50:13 GMTJohnson & Johnson Backs In Vivo CAR-T With a Three-Part Deal for Sail Biomedicines - BioBuzzBioBuzz · Fri, 31 Jul 2026 18:28:31 GMTJ&J secures $2.58bn option to buy in vivo CAR T firm Sail Biomedicines - BioXconomyBioXconomy · Fri, 31 Jul 2026 07:00:00 GMTJ&J Joins Immune Reset Race, Paying $785M to Partner on Sail Bio Cell Therapy - medcitynews.commedcitynews.com · Fri, 31 Jul 2026 00:47:45 GMTJ&J strikes CAR-T pact with Sail Bio, bags $2.58B buyout option - FirstWord PHARMAFirstWord PHARMA · Thu, 30 Jul 2026 12:26:36 GMTJ&J takes $2.58bn option to buy in vivo CAR-T firm Sail - pharmaphorum.compharmaphorum.com · Thu, 30 Jul 2026 10:54:17 GMTJ&J wagers on next cell therapy frontier with $2.6bn Sail Bio acquisition option - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Thu, 30 Jul 2026 10:44:32 GMT